BioMaxima S.A. (BMX.WA)
PLN 11.7
(-2.5%)
PLN 11.7
(-2.5%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 46.78 Million PLN | -67.48% |
| 2022 | 143.86 Million PLN | 81.91% |
| 2021 | 79.08 Million PLN | 28.37% |
| 2020 | 61.6 Million PLN | 102.08% |
| 2019 | 30.48 Million PLN | -1.07% |
| 2018 | 30.81 Million PLN | -2.4% |
| 2017 | 31.57 Million PLN | 17.01% |
| 2016 | 26.98 Million PLN | 22.85% |
| 2015 | 21.96 Million PLN | 7.46% |
| 2014 | 20.44 Million PLN | -2.5% |
| 2013 | 20.96 Million PLN | 11.41% |
| 2012 | 18.81 Million PLN | 79.37% |
| 2011 | 10.49 Million PLN | 46.45% |
| 2010 | 7.16 Million PLN | 7.41% |
| 2009 | 6.66 Million PLN | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 11.53 Million PLN | -13.6% |
| 2024 Q2 | 12.45 Million PLN | 8.04% |
| 2023 Q3 | 11.66 Million PLN | 8.75% |
| 2023 FY | 46.78 Million PLN | -67.48% |
| 2023 Q1 | 11.07 Million PLN | -17.03% |
| 2023 Q2 | 10.72 Million PLN | -3.15% |
| 2023 Q4 | 13.34 Million PLN | 14.41% |
| 2022 FY | 143.86 Million PLN | 81.91% |
| 2022 Q1 | 93.59 Million PLN | 305.97% |
| 2022 Q2 | 23.87 Million PLN | -74.49% |
| 2022 Q3 | 13.04 Million PLN | -45.36% |
| 2022 Q4 | 13.35 Million PLN | 2.34% |
| 2021 Q4 | 23.05 Million PLN | 58.03% |
| 2021 Q1 | 26.69 Million PLN | 12.33% |
| 2021 Q2 | 14.75 Million PLN | -44.72% |
| 2021 FY | 79.08 Million PLN | 28.37% |
| 2021 Q3 | 14.58 Million PLN | -1.11% |
| 2020 Q4 | 23.76 Million PLN | 64.87% |
| 2020 Q2 | 16.4 Million PLN | 133.06% |
| 2020 Q1 | 7.03 Million PLN | -17.06% |
| 2020 FY | 61.6 Million PLN | 102.08% |
| 2020 Q3 | 14.41 Million PLN | -12.13% |
| 2019 FY | 30.48 Million PLN | -1.07% |
| 2019 Q1 | 7.46 Million PLN | -9.82% |
| 2019 Q2 | 7.81 Million PLN | 4.69% |
| 2019 Q3 | 6.73 Million PLN | -13.83% |
| 2019 Q4 | 8.48 Million PLN | 26.06% |
| 2018 Q2 | 7.73 Million PLN | 2.36% |
| 2018 FY | 30.81 Million PLN | -2.4% |
| 2018 Q1 | 7.55 Million PLN | -5.57% |
| 2018 Q3 | 7.25 Million PLN | -6.14% |
| 2018 Q4 | 8.27 Million PLN | 14.0% |
| 2017 FY | 31.57 Million PLN | 17.01% |
| 2017 Q2 | 7.69 Million PLN | -1.3% |
| 2017 Q1 | 7.79 Million PLN | -27.79% |
| 2017 Q4 | 7.99 Million PLN | -0.78% |
| 2017 Q3 | 8.06 Million PLN | 4.75% |
| 2016 Q1 | 5.84 Million PLN | -2.78% |
| 2016 Q4 | 10.79 Million PLN | 119.03% |
| 2016 Q3 | 4.93 Million PLN | -8.85% |
| 2016 Q2 | 5.4 Million PLN | -7.47% |
| 2016 FY | 26.98 Million PLN | 22.85% |
| 2015 Q2 | 5.44 Million PLN | 3.62% |
| 2015 FY | 21.96 Million PLN | 7.46% |
| 2015 Q1 | 5.25 Million PLN | 2.07% |
| 2015 Q4 | 6.01 Million PLN | 14.51% |
| 2015 Q3 | 5.25 Million PLN | -3.58% |
| 2014 Q3 | 4.66 Million PLN | -9.76% |
| 2014 Q2 | 5.17 Million PLN | -5.02% |
| 2014 Q1 | 5.44 Million PLN | -30.54% |
| 2014 Q4 | 5.14 Million PLN | 10.27% |
| 2014 FY | 20.44 Million PLN | -2.5% |
| 2013 Q3 | 4.55 Million PLN | 4.71% |
| 2013 Q4 | 7.84 Million PLN | 72.33% |
| 2013 FY | 20.96 Million PLN | 11.41% |
| 2013 Q1 | 4.22 Million PLN | -64.19% |
| 2013 Q2 | 4.34 Million PLN | 2.93% |
| 2012 Q1 | 2.68 Million PLN | 0.0% |
| 2012 FY | 18.81 Million PLN | 79.37% |
| 2012 Q2 | 2.28 Million PLN | -14.86% |
| 2012 Q4 | 11.79 Million PLN | 474.01% |
| 2012 Q3 | 2.05 Million PLN | -10.17% |
| 2011 FY | 10.49 Million PLN | 46.45% |
| 2010 FY | 7.16 Million PLN | 7.41% |
| 2009 FY | 6.66 Million PLN | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Scope Fluidics S.A. | 516 Thousand PLN | -8967.054% |
| Selvita S.A. | 346.95 Million PLN | 86.515% |
| Voxel S.A. | 424.18 Million PLN | 88.97% |